ConductScience.org, home

Paper22460880

Drug development: Raise standards for preclinical cancer research.

Begley CG and 1 other. Nature, 2012. Cited by 1,694 papers, by iCite.

Cite this record

ConductScience Library. Drug development: Raise standards for preclinical cancer research. Papers, record 22460880. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22460880

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Drug development: Raise standards for preclinical cancer research.
PubMed
Journal
Nature
PubMed
Year
2012
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1,694
iCite
Relative citation ratio, by iCite
47.1
iCite
Revised in PubMed
2022-04-09
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Begley CGC Glenn
2Ellis LMLee M

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomedical ResearchMajor topic
Drug Evaluation, PreclinicalMajor topic
NeoplasmsMajor topic
Translational Research, BiomedicalMajor topic
Animals
Cell Line, Tumor
Clinical Trials as Topic
Humans
Mice
Reproducibility of Results
Research Design
Survival Analysis
Treatment Failure

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in22552083Preclinical trials: Keep 'reproducibility' in context.https://conductscience.org/library/papers/22552083

Source PubMed

Download CSV of comments and corrections

References5

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120531333Raising the bar for cancer therapy models.Nat Biotechnol2010https://conductscience.org/library/papers/20531333PubMed
220422014Do pressures to publish increase scientists' bias? An empirical support from US States Data.PLoS One2010https://conductscience.org/library/papers/20422014PubMed
322371130Drug development and clinical trials--the path to an approved cancer drug.Nat Rev Clin Oncol2012https://conductscience.org/library/papers/22371130PubMed
421448176High drug attrition rates--where are we going wrong?Nat Rev Clin Oncol2011https://conductscience.org/library/papers/21448176PubMed
521892149Believe it or not: how much can we rely on published data on potential drug targets?Nat Rev Drug Discov2011https://conductscience.org/library/papers/21892149PubMed

Download CSV of references

Cited by1,093

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,694 citations.

PMIDTitleJournalYearIn PapersSource
42953410Qualitative study reveals perceived barriers and facilitators of preregistration in animal research.R Soc Open Sci2026https://conductscience.org/library/papers/42953410PubMed
42922903Replication and replicability as epistemic opportunity for the humanities: reflections on a Rembrandt attribution case study.Humanit Soc Sci Commun2026https://conductscience.org/library/papers/42922903PubMed
42910235Human Induced Pluripotent Stem Cells in Rare Neurological Disorders: Opportunities and Challenges for Disease Modeling and Drug Discovery.Stem Cells Int2026https://conductscience.org/library/papers/42910235PubMed
42882581Reproducibility in Studies on Dental Restorative Materials: A Critical Review.Materials (Basel)2026https://conductscience.org/library/papers/42882581PubMed
42846679From Core Facility to Collaborative Partner: Reimagining Institutional Shared Resources as CRO-Model Research Partners Enhanced by Agentic AI.J Biomol Tech2026https://conductscience.org/library/papers/42846679PubMed
42842063Correspondence to: AdipoRon promotes angiogenesis in B-cell leukemia by modulating pro-angiogenic factors through AdipoR1.Mol Biol Rep2026https://conductscience.org/library/papers/42842063PubMed
42811190Reproducibility in biomedical research.Nat Med2026https://conductscience.org/library/papers/42811190PubMed
42804443From preclinical promise to regulatory reality: translation of small rodent acute injury therapies to human approval and safety outcomes: A systematic review.PLoS One2026https://conductscience.org/library/papers/42804443PubMed
42786286Localized immunotherapy via dissolving microneedles for the prevention of breast cancer recurrence.Drug Deliv Transl Res2026https://conductscience.org/library/papers/42786286PubMed
42786165Artificial intelligence in biomarker discovery for diseases: diagnostic and therapeutic prospects.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42786165PubMed
42737805
Multi-Target Antitumor Effects of Natural Products and Approved Drug Repurposing in Non-Small Cell Lung Cancer: Advances in Mechanisms, Combination Regimens, Delivery System Optimization, and Clinical Challenges.
Int J Mol Sci2026https://conductscience.org/library/papers/42737805PubMed
42728931Exploratory Insights into Barriers and Open Practices for Computational Reproducibility in Scientific Research.F1000Res2025https://conductscience.org/library/papers/42728931PubMed
42718899From bench to bedside: Overcoming translational hurdles in nanoparticle research with pharmacokinetic modeling.Bioeng Transl Med2026https://conductscience.org/library/papers/42718899PubMed
42711723Three-dimensional spheroid models in breast cancer: tumor microenvironment complexity, cancer stem cell-driven resistance, and translational model integration.J Transl Med2026https://conductscience.org/library/papers/42711723PubMed
42671246Cross-tissue immune profiling of APOE ε4 reveals early dysregulation in Alzheimer's disease.Alzheimers Dement2026https://conductscience.org/library/papers/42671246PubMed
42577796Stop comparing spells: a defense of mechanistic reasoning in quantitative medicine.Front Digit Health2026https://conductscience.org/library/papers/42577796PubMed
42576973Need for NAMs: A systematic evidence synthesis revealing over half a century of drug development failure.NAM J2026https://conductscience.org/library/papers/42576973PubMed
42543391Pharmacological evolution of natural product-based and chemically engineered autophagy-modulating strategies in neurodegenerative diseases: a bibliometric mapping analysis (2006-2025).Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42543391PubMed
42528866Commentary: Post-translational modifications in retinoblastoma: mechanisms, immune regulation, and therapeutic opportunities.Front Immunol2026https://conductscience.org/library/papers/42528866PubMed
42520002A survey of researchers' attitudes to preregistration in animal research reveals multiple perceived barriers to adoption.PLoS Biol2026https://conductscience.org/library/papers/42520002PubMed

See all 1,093 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22460880

GET https://conductscience.org/api/papers/v1/22460880/cited_by?page=2